Neha Patil (Editor)

OpenPHACTS

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Formation
  
2011

Type
  
Public–private partnership

Purpose
  
Semantic interoperability for drug discovery through Open innovation

Membership
  
27 member organisations

Key people
  
Antony John Williams Carole Goble Barend Mons Gerhard Ecker

Website
  
www.openphacts.org github.com/openphacts

Open PHACTS (Open Pharmacological Concept Triple Store) is a European initiative public–private partnership between academia, publishers, enterprises, pharmaceutical companies and other organisations working to enable better, cheaper and faster drug discovery. It has been funded by the Innovative Medicines Initiative, selected as part of three projects to "design methods for common standards and sharing of data for more efficient drug development and patient treatment in the future".

Contents

Partnerships

A total of 27 partners are currently involved including:

  • Academia: Maastricht University, University of Santiago de Compostela, University of Vienna, University of Manchester, University of Bonn, Swiss Institute of Bioinformatics, European Bioinformatics Institute, Vrije Universiteit of Amsterdam, Technical University of Denmark, University of Hamburg
  • Pharmaceutical companies: Pfizer, Merck KGaA, Eli Lilly and Company, Novartis, GlaxoSmithKline, AstraZeneca
  • Other companies: ChemSpider, Biovia, Eagle Genomics, Entagen
  • Publishers: Royal Society of Chemistry, Thomson Reuters
  • Drug discovery

    The Open Pharmacological Space created by the consortium is intended to support open innovation and in-house non-public drug discovery research by removing bottlenecks in drug development. Resources from the project are publicly available on GitHub.

    To reduce the barriers to drug discovery in industry, academia and for small businesses, the Open PHACTS consortium built the Open PHACTS Discovery Platform. This platform is freely available, integrating pharmacological data from a variety of information resources and providing tools and services to question this integrated data to support pharmacological research.

    References

    OpenPHACTS Wikipedia